| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/27/1992 | CA2060746A1 Manufacture of calcium hydrosilicate bound fiberboard |
| 08/26/1992 | EP0265508B1 Production and use of reaction product obtained from ascorbic acid with alpha,beta-unsaturated alicyclic ketone or vinyl aliphatic ketone |
| 08/25/1992 | US5142075 Anti-tumor platinum(II) complexes and process for the preparation thereof |
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna |
| 08/25/1992 | US5141958 Inhibition of cell adhesion for reducing cancer cell metastases |
| 08/25/1992 | US5141957 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
| 08/25/1992 | US5141943 Water soluble uridine phosphorylase inhibitors, reducing toxicity and anemia of antiviral drugs |
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/23/1992 | WO1992014478A1 Process for producing a medical composition with a bone marrow protective effect and an anti-neoplastic effect |
| 08/23/1992 | CA2101645A1 Process for the production of a pharmaceutical preparation for producing a protective effect on bone marrow and an antineoplastic effect |
| 08/22/1992 | WO1992014470A1 Treatment of esophageal cancer |
| 08/22/1992 | CA2104449A1 Treatment of esophageal cancer |
| 08/21/1992 | WO1992014716A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 08/21/1992 | CA2101542A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
| 08/20/1992 | WO1992013883A1 Lhrh antagonists |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013851A1 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances |
| 08/20/1992 | WO1992013826A1 Compositions and method for soft tissue tumors |
| 08/20/1992 | WO1992013568A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013554A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | WO1992013525A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/20/1992 | CA2101735A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2079896A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | CA2079461A1 Lhrh antagonists |
| 08/19/1992 | EP0499544A2 Use of tetrahydropiridin-derivatives as inhibitors of angiogenesis |
| 08/19/1992 | EP0499521A1 Inhibitors of N-myristoyltransferase, their preparation process and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499467A2 Use of quinones in the treatment of cancer or AIDS |
| 08/19/1992 | EP0499291A1 Treatment of malignant tumours with 8-chloroadenosine 3'-5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof |
| 08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0498883A1 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters |
| 08/19/1992 | EP0498843A1 Oligonucleotide analogs with novel linkages. |
| 08/19/1992 | CN1063615A Radiopharmaceutical formulations, their method of administration and process of preparation |
| 08/18/1992 | US5140044 Antitumor and -carcinogenic agents; protein kinase C inhibitors |
| 08/18/1992 | CA1306428C Monoclonal antibody specific for a mammary tumor cell surface antigen |
| 08/18/1992 | CA1306414C Affinity enhancement system |
| 08/15/1992 | CA2061173A1 Compositions comprising tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 08/14/1992 | WO1992014725A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| 08/14/1992 | WO1992014454A1 Use of quinones in the treatment of cancer or aids |
| 08/14/1992 | CA2104009A1 Use of quinones in the treatment of cancer or aids |
| 08/14/1992 | CA2101160A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) |
| 08/12/1992 | EP0498771A2 MSH peptide derivatives |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498333A2 Preparation of an organospecific substance marked with technetium-99m |
| 08/12/1992 | EP0497997A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497910A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 08/12/1992 | CN1063486A Deacetylcolchicine derivatives |
| 08/12/1992 | CA2060967A1 N-myristoyltransferase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2060699A1 Gm-csf inhibiting oligopeptides |
| 08/11/1992 | US5138059 Dc-89 compounds and process for their preparation |
| 08/11/1992 | US5138036 Inhibits growth of leukemia |
| 08/11/1992 | US5138035 Enzyme inhibitors |
| 08/11/1992 | US5137918 Anticancer agent |
| 08/11/1992 | US5137877 Bifunctional linking compounds, conjugates and methods for their production |
| 08/11/1992 | US5137720 Hybrid interferon polypeptide and muramylpeptide; synergistic |
| 08/11/1992 | CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
| 08/11/1992 | CA1306250C 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives |
| 08/11/1992 | CA1306213C Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
| 08/09/1992 | WO1992013869A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
| 08/09/1992 | CA2103721A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
| 08/06/1992 | WO1992012994A1 Mixed specificity fusion proteins |
| 08/06/1992 | WO1992012989A1 New sterol esters and sterol phosphorus compounds |
| 08/06/1992 | WO1992012963A1 23-oxa derivatives of d-series vitamins, method of preparing them, pharmaceutical preparations containing them, and the use of such preparations as drugs |
| 08/06/1992 | WO1992012726A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/06/1992 | WO1992012725A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | CA2100553A1 Treatment of neoplastic disease with interleukin-10 |
| 08/05/1992 | EP0497740A1 Benzyloxyphenyl derivatives |
| 08/05/1992 | EP0497356A1 Compositions and method for soft tissue tumors |
| 08/05/1992 | EP0497275A2 Generation of CD4+ helper T cells with interleukin 2 and interleukin 4 from L-phenylalanine methyl ester treated human peripheral blood cells |
| 08/05/1992 | EP0497274A2 Generation of adherent LAK cells with interleukin-2 and interleukin-4 |
| 08/05/1992 | EP0497234A2 Phosphatidylinositol analogues, inhibitors of phosphatidyl-inositol-specific phospholipase C |
| 08/05/1992 | CN1063308A Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/05/1992 | CN1063287A Process for preparation of 3'-fluoropyrimidine nucleosides |
| 08/04/1992 | US5136099 Golfomycin derivatives: fused ring cyclodecadiyne derivatives having dna-cleaving properties and antitumor activity |
| 08/04/1992 | US5136060 Method for preparation of taxol using an oxazinone |
| 08/04/1992 | US5135937 Aromatase inhibitors |
| 08/04/1992 | US5135745 Anticancer, antitumor agent |
| 08/04/1992 | CA1305972C STABLE SOLVENT ADDUCTS OF Z-1-(P-.beta.- DIMETHYLAMINOETHOXY-PHENYL)-1-(P-HYDROXYPHENYL)-2- PHENYL-BUT-1-ENE |
| 08/04/1992 | CA1305970C Process for producing ifosfamide having improved properties |
| 08/02/1992 | CA2060352A1 Benzyloxyphenyl derivatives |
| 08/02/1992 | CA2060083A1 Phosphatidylinositol analogues, inhibitors of phosphatidylinositol-specific phospholipase c |
| 08/01/1992 | CA2060278A1 Enhanced generation of adherent lymphokine-activated killer cells with interleukin-2 and interleukin-4 from l-phenylalanine methyl ester-treated human peripheral blood cells |
| 08/01/1992 | CA2060270A1 Generation of cd4 helper t cells with interleukin 2 and interleukin 4 from l-phenylalanine methyl ester treated human peripheral blood cells |
| 07/30/1992 | WO1992012636A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/30/1992 | CA2101780A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/29/1992 | EP0496641A2 Cobalt complexes as anticancer agents |
| 07/29/1992 | EP0496606A1 Vav proto-oncogene protein |
| 07/29/1992 | EP0496162A2 Peptide inhibitors of RAS-GAP interaction |
| 07/29/1992 | EP0496160A1 Synthetic conversion of bryostatin 2 into bryostatin 1 |
| 07/29/1992 | CN1063102A Phenylimidazolidines, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 07/29/1992 | CN1017626B Growth resulating factor for new cell |
| 07/28/1992 | US5134156 Pharmaceutical composition and method for angiogenesis inhibition |